DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
Purpose
The DRAGON registry aims to collect data on combined portal and hepatic vein embolization (PVE/HVE) for liver tumors, a technique expected to enhance liver regeneration compared to standard PVE. This collaborative registry focuses on identifying associations between baseline clinical/imaging parameters, clinical outcomes, and safety for patients undergoing PVE/HVE.
Conditions
- Liver Cancer
- Liver Metastases
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Criteria
Inclusion Criteria:
- Patients who have undergone PVE/HVE or technical variations on this procedure
- 18 Years and older
- Men and women
Study Design
- Phase
- Study Type
- Observational [Patient Registry]
- Observational Model
- Cohort
- Time Perspective
- Other
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
| PVE/HVE | This registry collects data on patients who have undergone combined portal and hepatic vein embolisation prior to major liver surgery. |
Recruiting Locations
Rush University Medical Center
Chicago, Illinois 60612
Chicago, Illinois 60612
Mayo Clinic
Rochester, Minnesota 55905
Rochester, Minnesota 55905
Cleveland Clinic
Cleveland, Ohio 44195
Cleveland, Ohio 44195
More Details
- Status
- Recruiting
- Sponsor
- Maastricht University Medical Center
Detailed Description
Retrospective and prospective